These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8250098)

  • 1. Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections.
    Silva JS; Barral-Netto M; Reed SG
    Am J Trop Med Hyg; 1993 Nov; 49(5):589-97. PubMed ID: 8250098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses.
    Doherty TM; Morse HC; Coffman RL
    Int Immunol; 1995 Jan; 7(1):131-8. PubMed ID: 7718509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
    Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
    Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses.
    Gazzinelli RT; Hartley JW; Fredrickson TN; Chattopadhyay SK; Sher A; Morse HC
    Infect Immun; 1992 Oct; 60(10):4394-401. PubMed ID: 1328058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi.
    Torrecilhas AC; Faquim-Mauro E; Da Silva AV; Abrahamsohn IA
    Immunology; 1999 Mar; 96(3):381-8. PubMed ID: 10233719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
    Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
    Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
    Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
    J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice.
    Sasaki H; Kobayashi M; Pollard RB; Suzuki F
    Pathobiology; 2001; 69(2):96-103. PubMed ID: 11752903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
    Akarid K; Pocidalo MA; Desforges B; Sinet M
    Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th0-like CD4+ T cells protect mice with murine retrovirus-induced immunodeficiency syndrome (MAIDS) against co-infection with Listeria monocytogenes.
    Hiromatsu K; Nishimura H; Kimura K; Aoki Y; Usami J; Kobayashi N; Makino M; Yoshikai Y
    Immunology; 1996 Dec; 89(4):532-8. PubMed ID: 9014817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression.
    Beilharz MW; Sammels LM; Paun A; Shaw K; van Eeden P; Watson MW; Ashdown ML
    J Immunol; 2004 Apr; 172(8):4917-25. PubMed ID: 15067071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.
    Giese NA; Gazzinelli RT; Actor JK; Morawetz RA; Sarzotti M; Morse HC
    Immunology; 1996 Mar; 87(3):467-74. PubMed ID: 8778035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus.
    Uehara S; Hitoshi Y; Numata F; Makino M; Howard M; Mizuochi T; Takatsu K
    Int Immunol; 1994 Dec; 6(12):1937-47. PubMed ID: 7696211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS; Tarleton RL
    J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection.
    Martins GA; Campanelli AP; Silva RB; Tadokoro CE; Russo M; Cunha FQ; Rizzo LV; Silva JS
    Microbes Infect; 2004 Nov; 6(13):1133-44. PubMed ID: 15488732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.